Hengan International Lifts 2025 Profit on Higher Margins and Efficiency Gains
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Hengan International Group Co ( (HK:1044) ) is now available.
Hengan International reported a modest 1.8% rise in 2025 revenue to RMB23.07 billion, driven by a 1.9% increase in its core tissue and hygiene products business, while gross margin improved to 33.8% from 32.3%. Profit attributable to shareholders climbed 10.3% to RMB2.54 billion, lifting basic earnings per share to RMB2.227 and supporting unchanged interim and final dividends of RMB0.70 per share.
Operational metrics showed improved efficiency, with accounts receivable turnover days falling to 36 from 39 and finished goods turnover days improving to 42 from 46. The group’s operating profit rose 3.9% to RMB3.48 billion and its rate of return increased to 11.6%, underscoring stronger profitability despite a slightly lower current ratio, and signaling resilient performance for investors in a competitive consumer products market.
The most recent analyst rating on (HK:1044) stock is a Hold with a HK$24.60 price target. To see the full list of analyst forecasts on Hengan International Group Co stock, see the HK:1044 Stock Forecast page.
More about Hengan International Group Co
Hengan International Group Company Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the consumer goods sector. The group focuses on tissue and hygiene products as its core business segments, serving mass-market household and personal care demand in mainland China and broader Asian markets.
Average Trading Volume: 2,843,346
Technical Sentiment Signal: Hold
Current Market Cap: HK$32.62B
For a thorough assessment of 1044 stock, go to TipRanks’ Stock Analysis page.
